Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Evidence for Evolution02:55

The Evidence for Evolution

47.7K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
47.7K
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

271
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
271
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

479
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
479
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

293
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
293
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

225
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
225
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

425
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
425

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromosome-scale genome assembly and characterization of Saccharomycopsis schoenii, a necrotrophic predatory yeast.

G3 (Bethesda, Md.)·2026
Same author

Correction: Programmed cell death and redox metabolism protect Chlamydomonas reinhardtii populations from the galactic cosmic environment on the Artemis-1 mission.

Scientific reports·2025
Same author

Postpartum psychiatric hospital admissions: A population-based study from British Columbia, Canada.

Psychiatry research·2025
Same author

Barcode sequencing: a robust, platform-agnostic method for massively parallel cell-based screens.

G3 (Bethesda, Md.)·2025
Same author

Programmed cell death and redox metabolism protect Chlamydomonas reinhardtii populations from the galactic cosmic environment on the Artemis-1 mission.

Scientific reports·2025
Same author

CDADC1 is a vertebrate-specific dCTP deaminase that metabolizes gemcitabine and decitabine to prevent cellular toxicity.

Proceedings of the National Academy of Sciences of the United States of America·2025

Related Experiment Video

Updated: Jan 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.6K

Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges.

Catriona Hippman1,2, Corey Nislow3

  • 1Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, BC, V6T 2A1, Canada. Catriona.hippman@ubc.ca.

Journal of Personalized Medicine
|August 10, 2019
PubMed
Summary
This summary is machine-generated.

Pharmacogenomics tailors treatments to individual genetic makeup, reducing adverse drug events. Advances in next-generation sequencing (NGS) improve genotyping, but low genomic literacy hinders patient care implementation.

Keywords:
clinical guidelinesdrugsimplementationmedicationspharmacogenomicsreview

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
09:52

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

1.3K

Related Experiment Videos

Last Updated: Jan 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.6K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease
09:52

A Clinical Metaproteomics Workflow Implemented within Galaxy Bioinformatics Platform to Analyze Host-Microbiome Interactions Underlying Human Disease

Published on: January 10, 2025

1.3K

Area of Science:

  • Clinical Pharmacology
  • Genomics
  • Translational Medicine

Background:

  • Pharmacogenomics offers personalized medicine by tailoring treatments to genetic profiles, minimizing adverse drug reactions.
  • The number of pharmacogenomic guidelines and drug label inclusions has grown significantly, indicating increased clinical relevance.
  • Accessible genotyping technologies, like next-generation sequencing (NGS), facilitate simultaneous analysis of multiple pharmacogenomic loci.

Purpose of the Study:

  • To highlight the growing importance and accessibility of pharmacogenomics in clinical practice.
  • To address the gap between research advancements in pharmacogenomics and clinical implementation.
  • To emphasize the need for multidisciplinary collaboration in pharmacogenomically-informed patient care.

Main Methods:

  • Review of current pharmacogenomic guidelines and drug labeling data.
  • Discussion of advancements in genotyping technologies, specifically next-generation sequencing (NGS).
  • Analysis of the challenges in translating genomic knowledge into clinical practice, focusing on genomic literacy.

Main Results:

  • As of June 2019, 132 pharmacogenomic dosing guidelines exist for 99 drugs, with 309 medication labels containing pharmacogenomic information.
  • Next-generation sequencing (NGS) provides a cost-effective method for comprehensive patient genotyping.
  • Despite technological progress, low genomic literacy presents a significant barrier to the effective implementation of pharmacogenomics.

Conclusions:

  • Pharmacogenomics is crucial for enhancing patient care through personalized treatments and reduced adverse events.
  • Multidisciplinary teams are essential for integrating pharmacogenomic data into routine clinical practice.
  • Bridging the knowledge gap in genomic literacy is vital for successful pharmacogenomic implementation and improved patient outcomes.